Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.513NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.4.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
HN.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.4.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XACORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XACENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XACENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XACNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XZORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XZENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XZENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XZNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.6.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.6.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.6.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBJORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBJENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBJNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EJ.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EJ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EJ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EJ.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DQ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.31.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.31.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.31.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.31.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.77ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used